China Pharma (NYSE:CPHI) Now Covered by StockNews.com

Analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock.

China Pharma Price Performance

Shares of CPHI opened at $0.24 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24. China Pharma has a one year low of $0.17 and a one year high of $1.21. The business’s 50 day simple moving average is $0.21 and its 200-day simple moving average is $0.27.

China Pharma (NYSE:CPHI) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%. The firm had revenue of $0.93 million for the quarter.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.